Financhill
Back

Eisai 10K Form

Sell
27

ESALF
Eisai

Last Price:
40.82
Seasonality Move:
13.95%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ESALF News And Ratings

See the #1 stock for the next 7 days that we like better than ESALF

ESALF Financial Statistics

Sales & Book Value

Annual Sales: $6.74B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $20.59
Price / Book: 0

Profitability

EPS (TTM): 0.66000
Net Income (TTM): $189.29M
Gross Margin: $5.18B
Return on Equity: 0%
Return on Assets: 0%

Eisai Earnings Forecast

Key Eisai Financial Ratios

  • The Gross Profit Margin over the past 23 years for ESALF is 76.88%.
  • The Selling, General & Administrative Expenses for ESALF have been equal to 48.46% of Gross Profit Margin.
  • The Research & Development expenses have been 22.71% of Revenue.
  • The Interest Expense is 3.53% of Operating Income.
  • The Net Earning history of ESALF is 6.34% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 15 years.

Eisai Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: ESALF
Website: eisai.co.jp

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ESALF Technical Analysis vs Fundamental Analysis

Sell
27
Eisai (ESALF) is a Sell

Is Eisai a Buy or a Sell?

  • Eisai stock is rated a Sell
    The current Eisai [ESALF] share price is $40.82. The Score for ESALF is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.